Todd Dunn of Accuryn

We monitor the heart, brain, and lungs in real time. But the kidneys? Most hospitals are still using a gravity-fed catheter from 1933 and eyeballing a bag every few hours. On this episode of the Kinetic Innovators Podcast, I sat down with Todd Dunn, CEO of Accuryn, to talk about why acute kidney injury is one of the biggest patient safety problems hiding in plain sight, and what his team is doing to change that. Some numbers that hit hard: Over 3 million AKI events per year in U.S. hospitals. That's roughly one every 10 seconds. CMS declared it a hospital-acquired harm in 2024. 62% of AKI patients are readmitted within 90 days. The cost of an AKI stay is nearly double a typical admission. Accuryn's technology digitizes kidney function at the bedside, giving nurses and physicians real-time fluid output and intra-abdominal pressure data that flows straight into the EMR. Their system can flag kidney injury by the urine standard up to 12 hours before the blood test catches it. That's half a day of lead time to intervene. Todd's story is worth the listen on its own. He went from volunteering for an innovation program at GE Healthcare, to being told "write your own job description" at Intermountain, to becoming a customer of Accuryn's device at Atrium Health, to becoming CEO. He liked the product so much he ended up running the company. We also got into where this is heading: pairing continuous kidney data with agentic AI to detect patient deterioration across the full hemodynamic picture. That conversation alone is worth your time. Todd has a book on healthcare innovation coming out in November, so we will be having him back. Want to reach Todd directly? [email protected] If this resonated, drop a comment, hit subscribe, and share it with someone in acute care who needs to see this. #KineticInnovatorsPodcast #HealthcareInnovation #AcuteKidneyInjury #Accuryn #PatientSafety #MedTech #DigitalHealth